Skip to content
buyWeak cluster of 410b5-1 plan

Kenneth Krogulski bought $4,824 of CPIX

director at CUMBERLAND PHARMACEUTICALS INC. 945 shares at an average of $5.11, traded May 1, 2025, filed Jun 6, 2025.

Conviction score
19
Value
$4,824
945 shares
Holdings after
285,698
+0% from before
From 52-week low
+354%
low $0.82, close $3.73
From 52-week high
-29%
high $5.25, as of May 1, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $5k at market
    0
  • Relative to holdings
    Under 1% of holdings (0.3%)
    -5
  • Price context
    29% below the 52-week high
    +4
  • Cluster
    4 insiders buying within 14 days
    +15
  • Repeat buying
    3 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (1 with prices)
    0
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -15

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CPIXOct 9, 2026 · close 7.03
Since filing Jun 6, 2025: +55.8%SPY +32.1% · excess +23.7%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001628280-25-029856, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 1, 2025POpen-market purchase
Common Stock10b5-1
+45$4.86$219284,798Jun 6, 2025
May 2, 2025POpen-market purchase
Common Stock10b5-1
+45$4.75$214284,843Jun 6, 2025
May 5, 2025POpen-market purchase
Common Stock10b5-1
+45$4.68$211284,888Jun 6, 2025
May 6, 2025POpen-market purchase
Common Stock10b5-1
+45$4.60$207284,933Jun 6, 2025
May 7, 2025POpen-market purchase
Common Stock10b5-1
+45$4.71$212284,978Jun 6, 2025
May 8, 2025POpen-market purchase
Common Stock10b5-1
+45$4.50$203285,023Jun 6, 2025
May 9, 2025POpen-market purchase
Common Stock10b5-1
+45$4.78$215285,068Jun 6, 2025
May 12, 2025POpen-market purchase
Common Stock10b5-1
+45$5.25$236285,113Jun 6, 2025
May 13, 2025POpen-market purchase
Common Stock10b5-1
+45$5.67$255285,158Jun 6, 2025
May 14, 2025POpen-market purchase
Common Stock10b5-1
+45$5.68$256285,203Jun 6, 2025
May 15, 2025POpen-market purchase
Common Stock10b5-1
+45$5.20$234285,248Jun 6, 2025
May 16, 2025POpen-market purchase
Common Stock10b5-1
+45$5.37$242285,293Jun 6, 2025
May 19, 2025POpen-market purchase
Common Stock10b5-1
+45$4.92$221285,338Jun 6, 2025
May 20, 2025POpen-market purchase
Common Stock10b5-1
+45$5.41$243285,383Jun 6, 2025
May 21, 2025POpen-market purchase
Common Stock10b5-1
+45$5.05$227285,428Jun 6, 2025
May 22, 2025POpen-market purchase
Common Stock10b5-1
+45$5.10$230285,473Jun 6, 2025
May 23, 2025POpen-market purchase
Common Stock10b5-1
+45$5.14$231285,518Jun 6, 2025
May 27, 2025POpen-market purchase
Common Stock10b5-1
+45$5.27$237285,563Jun 6, 2025
May 28, 2025POpen-market purchase
Common Stock10b5-1
+45$5.68$256285,608Jun 6, 2025
May 29, 2025POpen-market purchase
Common Stock10b5-1
+45$5.66$255285,653Jun 6, 2025
May 30, 2025POpen-market purchase
Common Stock10b5-1
+45$4.93$222285,698Jun 6, 2025

Related signals

Other insiders at CUMBERLAND PHARMACEUTICALS INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$4,516
1,372 shares
+0%
33Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$862
262 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$862
262 shares
+1%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Caroline Young
director
$398
121 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$5,872
1,712 shares
+1%
33Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$1,166
340 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$1,166
340 shares
+1%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Caroline Young
director
$578
168 shares
+1%
19Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$4,513
935 shares
+0%
19Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$807
168 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kenneth Krogulski bought $4,824 of CPIX | InsiderTell